THN102

Theranexus · Phase 1 active Small molecule

At a glance

Generic name	THN102
Sponsor	Theranexus
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Safety and Efficacy of THN102 in Patients With Parkinson's Disease and Excessive Daytime Sleepiness (PHASE2)
Safety and Efficacy of THN102 on Sleepiness in Narcoleptic Patients (PHASE2)
Impact of THN102 on Attention, Wakefulness and Cognitive Performance During Total Sleep Deprivation (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

THN102 CI brief — competitive landscape report
THN102 updates RSS · CI watch RSS
Theranexus portfolio CI